Navigation Links
National Pharmaceutical Council Survey Shows Health Care Stakeholders Continue to Show Optimism About the Future Role of Comparative Effectiveness Research

WASHINGTON, March 19, 2013 /PRNewswire-USNewswire/ -- As the implementation of the Affordable Care Act (ACA) picks up speed, a new survey shows that health care stakeholders have growing expectations for the use of comparative effectiveness research (CER) as a tool for improving health care decision-making. The survey, the third in an annual series conducted by the National Pharmaceutical Council, also indicates that stakeholders are looking increasingly to the Patient-Centered Outcomes Research Institute (PCORI) as a leader in the CER effort.

"The potential for CER to re-shape the health care landscape is real, but the survey indicates that the actual impact is still on the horizon," said Dan Leonard , president of NPC. "Many health care stakeholders are not seeing an immediate impact from CER, but they do expect CER to have a larger impact on decision-making during the next five years."

During the next year, there is tempered optimism about CER, with 31 percent of respondents saying that CER will have a "moderate improvement" on health-care decision making over the next 12 months, which is a seven percentage point increase from 2012. It's during the next few years in which the full impact of CER is expected. Respondents felt much more confident about the impact of CER on health care decision-making over the next three to five years, with a "moderate improvement" indicated by 51 percent in the next three years, and 31 percent in the next five years. A "substantial improvement" was indicated by 24 percent over the next three years and 55 percent over the next five years.

Survey respondents also were asked which organizations they viewed as playing leading roles in CER. PCORI is viewed as leading on establishing research priorities (73 percent), closely followed by the National Institutes of Health (NIH) and the Agency for Healthcare Research and Quality (AHRQ) (67 percent and 65 percent, respectively). When it comes to funding and monitoring research, however, NIH is still perceived as playing the leading role in these areas, but to a significantly lesser extent than in previous years (69 percent in 2013 vs. 85 percent in 2012). The pharmaceutical industry followed at 66 percent, with PCORI at 61 percent, which are nearly identical to 2012 responses. Both FDA and private health plans are beginning to pop up on respondents' radars as playing a role in funding and monitoring research.

"We're expecting many groups to have a significant voice in the CER conversation during the coming years," said Kimberly Westrich , director for health services research for NPC. "Yet, we'll likely see a clearer picture emerge as the research priorities identified in the last year yield results that stakeholders can use." 

According to respondents, the actual work in conducting research is still expected to fall overwhelmingly to academia (82 percent) and the pharmaceutical industry (67 percent), mirroring the trend from previous years.

When compared to data from 2010, the survey also showed that respondents believe efforts to advance research standards and move toward integrated purchasing decisions have made modest gains during the past three years. Only 16 percent of respondents said that there were no widely agreed-upon research standards, down from 38 percent in 2010. The percent of respondents who said there were widely-agreed upon standards rose from 7 percent to 10 percent. Respondents who thought purchasing decisions took an individual, "siloed," view of services declined from 62 percent to 39 percent, signaling that efforts toward integration may be breaking through.

The survey, conducted by Scientific & Social Systems on behalf of NPC, was fielded between September 2012 and January 2013 among key stakeholders impacted by CER, including researchers/thought leaders; government; insurers and health plans; employers; business coalitions/human resources specialists; and associations/trade groups. A total of 114 stakeholders participated.

Complete survey results, the survey instrument, and related materials are available on NPC's website at

About the National Pharmaceutical Council
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit and follow NPC on Twitter @npcnow.

SOURCE National Pharmaceutical Council
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
2. Austen BioInnovation Institute in Akron Attracts Nationally Known Speakers For Conference on Value-driven Engineering, April 23-24
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
5. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
6. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
7. Fuse Science Partners With GNC To Open National Distribution Of EnerJel™
8. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
9. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
10. WAISMANN METHOD® Director Encourages Public to Participate in National Take-Back Day
11. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
Post Your Comments:
(Date:10/13/2015)... DUBLIN , Oct. 9, 2015 Research ... of the "Kombucha Market by Types (Bacteria, Yeast, ... Coconut & Mangoes, Flowers, Others), & by Region - ... --> --> ... in the last few years. In terms of value, ...
(Date:10/13/2015)... Oct. 13, 2015 WuXi PharmaTech (Cayman) ... technology platform company serving the pharmaceutical, biotechnology, and ... launched a mobile version of OncoWuXi, the first ... access oncology models and data on the go.  ... at any time to identify relevant tumor models ...
(Date:10/13/2015)... , Oct. 13, 2015  The Wyss ... University today announced the launch of its ... Ultivue will introduce imaging reagents providing super-resolution ... those of expensive specialized instruments. The announcement ... Harvard,s Office of Technology Development (OTD) ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... 13, 2015 , ... Boulder native and lifelong athlete, Mark ... power. Tested by Olympic and professional athletes, he developed the combined massage and ... in sporting equipment and high-tech sales led him to transition from Rally Software ...
(Date:10/13/2015)... FL (PRWEB) , ... October 13, 2015 , ... Vision ... Laser Vision of San Diego, California. With brands including The LASIK Vision Institute and ... procedures, making it the nationwide leader in laser vision correction. , Global Laser Vision ...
(Date:10/13/2015)... PITTSBURGH, PA (PRWEB) , ... October 13, 2015 , ... ... and digging his fists into his infected cheeks," said an inventor from Platteville, Colo. ... irritating their skin problems." , He developed the UNTOUCHABLE to prevent a child from ...
(Date:10/13/2015)... ... October 13, 2015 , ... HealthAware ... at HIMSS’s Patient Engagement Summit . HealthAware is a technology company focused ... programs and interventions via mobile devices that provide a framework for the development ...
(Date:10/13/2015)... ... 13, 2015 , ... Altec Products, Inc., the leader in ... Dynamics AXUG, GPUG and NAVUG Summits to take place the week of October ... user conferences designed and led by users to provide attendees with a unique ...
Breaking Medicine News(10 mins):